General Counsel Profile: Bristol-Myers Squibb Co.

General Counsel Sandra Leung discusses the legal ramifications of Bristol-Myers Squibb’s transformation into a "next-generation biopharmaceutical company."

By | 2010-11-19T00:46:22+00:00 November 19th, 2010|Uncategorized|0 Comments

Leave A Comment

google-site-verification: googlede575d7e284d2c39.html